<![CDATA[How KRAS-Targeted Therapy May Advance Toward Cancer Prevention]]>

Summary

Frank McCormick discussed his vision for using KRAS-targeted therapy to preemptively treat KRAS-driven precancerous lesions and prevent cancer development. The discussion covered differences between KRAS allele subtypes and future directions for the field.